Predictors of long-term outcome of functional dyspepsia and duodenal ulcer after successful Helicobacter pylori eradication - A 7-year follow-up study

Giovanni Maconi, Massimo Sainaghi, Mirko Molteni, Matteo Bosani, Silvano Gallus, Giorgio Ricci, Vittorio Alvisi, Gabriele Bianchi Porro

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

AIMS: To investigate the course of dyspeptic symptoms, predictors of symptom relief and use of antidyspeptic drugs in patients with duodenal ulcer disease and functional dyspepsia 6-7 years after successful Helicobacter pylori eradication. PATIENTS AND METHODS: Patients with H. pylori-positive duodenal ulcer or functional dyspepsia, included in a prospective, randomized study from January 1996 to June 1997, and successfully treated with standard triple therapy, were eligible. After 6-7 years, case histories of 142 patients were retrieved and patients were interviewed by telephone. They were asked about the presence of dyspeptic symptoms and health care needs during the last week and over the last 6-7 years. Predictive factors of complete long-term relief of symptoms have been evaluated. RESULTS: Of the 114 eligible patients, 104 (49 with duodenal ulcer and 55 with functional dyspepsia) were included in the study. The mean duration of follow up was 6.6±0.5 years. Complete relief of dyspeptic symptoms was reported, in this period, by 49.0% of duodenal ulcer patients and 36.4% of patients with functional dyspepsia (P=0.271). Persistence of symptoms within 3 months of H. pylori eradication and female sex were predictive of persistence of symptoms in the following 6-7 years, in patients with functional dyspepsia. In turn, approximately 50% of the patients with complete symptom remission, within 6 months of H. pylori eradication, later became symptomatic. Since the end of the H. pylori eradication trial, 26.9% of patients were still using or had used antidyspeptic drugs; patients with functional dyspepsia having used them more frequently than duodenal ulcer patients (36.4 vs. 16.3%; P=0.037). CONCLUSION: In clinical practice, long-term symptomatic benefit, in duodenal ulcer patients, after H. pylori eradication, is similar to that in patients with functional dyspepsia. Early evaluation of symptoms after successful H. pylori eradication may be predictive of outcome in dyspeptic patients. Most symptomatic patients did not seek antidyspeptic drugs. Use of antisecretory medications was, however, greater in patients with functional dyspepsia than in duodenal ulcer patients.

Original languageEnglish
Pages (from-to)387-393
Number of pages7
JournalEuropean Journal of Gastroenterology and Hepatology
Volume21
Issue number4
DOIs
Publication statusPublished - Apr 2009

Fingerprint

Dyspepsia
Duodenal Ulcer
Helicobacter pylori
Pharmaceutical Preparations
Duodenal Diseases
Symptom Assessment

Keywords

  • Duodenal ulcer
  • Dyspepsia
  • Eradication
  • Helicobacter pylori
  • Predictors

ASJC Scopus subject areas

  • Gastroenterology
  • Hepatology

Cite this

Predictors of long-term outcome of functional dyspepsia and duodenal ulcer after successful Helicobacter pylori eradication - A 7-year follow-up study. / Maconi, Giovanni; Sainaghi, Massimo; Molteni, Mirko; Bosani, Matteo; Gallus, Silvano; Ricci, Giorgio; Alvisi, Vittorio; Porro, Gabriele Bianchi.

In: European Journal of Gastroenterology and Hepatology, Vol. 21, No. 4, 04.2009, p. 387-393.

Research output: Contribution to journalArticle

Maconi, Giovanni ; Sainaghi, Massimo ; Molteni, Mirko ; Bosani, Matteo ; Gallus, Silvano ; Ricci, Giorgio ; Alvisi, Vittorio ; Porro, Gabriele Bianchi. / Predictors of long-term outcome of functional dyspepsia and duodenal ulcer after successful Helicobacter pylori eradication - A 7-year follow-up study. In: European Journal of Gastroenterology and Hepatology. 2009 ; Vol. 21, No. 4. pp. 387-393.
@article{b4416cf1b13946cf84dc5311574fab58,
title = "Predictors of long-term outcome of functional dyspepsia and duodenal ulcer after successful Helicobacter pylori eradication - A 7-year follow-up study",
abstract = "AIMS: To investigate the course of dyspeptic symptoms, predictors of symptom relief and use of antidyspeptic drugs in patients with duodenal ulcer disease and functional dyspepsia 6-7 years after successful Helicobacter pylori eradication. PATIENTS AND METHODS: Patients with H. pylori-positive duodenal ulcer or functional dyspepsia, included in a prospective, randomized study from January 1996 to June 1997, and successfully treated with standard triple therapy, were eligible. After 6-7 years, case histories of 142 patients were retrieved and patients were interviewed by telephone. They were asked about the presence of dyspeptic symptoms and health care needs during the last week and over the last 6-7 years. Predictive factors of complete long-term relief of symptoms have been evaluated. RESULTS: Of the 114 eligible patients, 104 (49 with duodenal ulcer and 55 with functional dyspepsia) were included in the study. The mean duration of follow up was 6.6±0.5 years. Complete relief of dyspeptic symptoms was reported, in this period, by 49.0{\%} of duodenal ulcer patients and 36.4{\%} of patients with functional dyspepsia (P=0.271). Persistence of symptoms within 3 months of H. pylori eradication and female sex were predictive of persistence of symptoms in the following 6-7 years, in patients with functional dyspepsia. In turn, approximately 50{\%} of the patients with complete symptom remission, within 6 months of H. pylori eradication, later became symptomatic. Since the end of the H. pylori eradication trial, 26.9{\%} of patients were still using or had used antidyspeptic drugs; patients with functional dyspepsia having used them more frequently than duodenal ulcer patients (36.4 vs. 16.3{\%}; P=0.037). CONCLUSION: In clinical practice, long-term symptomatic benefit, in duodenal ulcer patients, after H. pylori eradication, is similar to that in patients with functional dyspepsia. Early evaluation of symptoms after successful H. pylori eradication may be predictive of outcome in dyspeptic patients. Most symptomatic patients did not seek antidyspeptic drugs. Use of antisecretory medications was, however, greater in patients with functional dyspepsia than in duodenal ulcer patients.",
keywords = "Duodenal ulcer, Dyspepsia, Eradication, Helicobacter pylori, Predictors",
author = "Giovanni Maconi and Massimo Sainaghi and Mirko Molteni and Matteo Bosani and Silvano Gallus and Giorgio Ricci and Vittorio Alvisi and Porro, {Gabriele Bianchi}",
year = "2009",
month = "4",
doi = "10.1097/MEG.0b013e3283069db0",
language = "English",
volume = "21",
pages = "387--393",
journal = "European Journal of Gastroenterology and Hepatology",
issn = "0954-691X",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - Predictors of long-term outcome of functional dyspepsia and duodenal ulcer after successful Helicobacter pylori eradication - A 7-year follow-up study

AU - Maconi, Giovanni

AU - Sainaghi, Massimo

AU - Molteni, Mirko

AU - Bosani, Matteo

AU - Gallus, Silvano

AU - Ricci, Giorgio

AU - Alvisi, Vittorio

AU - Porro, Gabriele Bianchi

PY - 2009/4

Y1 - 2009/4

N2 - AIMS: To investigate the course of dyspeptic symptoms, predictors of symptom relief and use of antidyspeptic drugs in patients with duodenal ulcer disease and functional dyspepsia 6-7 years after successful Helicobacter pylori eradication. PATIENTS AND METHODS: Patients with H. pylori-positive duodenal ulcer or functional dyspepsia, included in a prospective, randomized study from January 1996 to June 1997, and successfully treated with standard triple therapy, were eligible. After 6-7 years, case histories of 142 patients were retrieved and patients were interviewed by telephone. They were asked about the presence of dyspeptic symptoms and health care needs during the last week and over the last 6-7 years. Predictive factors of complete long-term relief of symptoms have been evaluated. RESULTS: Of the 114 eligible patients, 104 (49 with duodenal ulcer and 55 with functional dyspepsia) were included in the study. The mean duration of follow up was 6.6±0.5 years. Complete relief of dyspeptic symptoms was reported, in this period, by 49.0% of duodenal ulcer patients and 36.4% of patients with functional dyspepsia (P=0.271). Persistence of symptoms within 3 months of H. pylori eradication and female sex were predictive of persistence of symptoms in the following 6-7 years, in patients with functional dyspepsia. In turn, approximately 50% of the patients with complete symptom remission, within 6 months of H. pylori eradication, later became symptomatic. Since the end of the H. pylori eradication trial, 26.9% of patients were still using or had used antidyspeptic drugs; patients with functional dyspepsia having used them more frequently than duodenal ulcer patients (36.4 vs. 16.3%; P=0.037). CONCLUSION: In clinical practice, long-term symptomatic benefit, in duodenal ulcer patients, after H. pylori eradication, is similar to that in patients with functional dyspepsia. Early evaluation of symptoms after successful H. pylori eradication may be predictive of outcome in dyspeptic patients. Most symptomatic patients did not seek antidyspeptic drugs. Use of antisecretory medications was, however, greater in patients with functional dyspepsia than in duodenal ulcer patients.

AB - AIMS: To investigate the course of dyspeptic symptoms, predictors of symptom relief and use of antidyspeptic drugs in patients with duodenal ulcer disease and functional dyspepsia 6-7 years after successful Helicobacter pylori eradication. PATIENTS AND METHODS: Patients with H. pylori-positive duodenal ulcer or functional dyspepsia, included in a prospective, randomized study from January 1996 to June 1997, and successfully treated with standard triple therapy, were eligible. After 6-7 years, case histories of 142 patients were retrieved and patients were interviewed by telephone. They were asked about the presence of dyspeptic symptoms and health care needs during the last week and over the last 6-7 years. Predictive factors of complete long-term relief of symptoms have been evaluated. RESULTS: Of the 114 eligible patients, 104 (49 with duodenal ulcer and 55 with functional dyspepsia) were included in the study. The mean duration of follow up was 6.6±0.5 years. Complete relief of dyspeptic symptoms was reported, in this period, by 49.0% of duodenal ulcer patients and 36.4% of patients with functional dyspepsia (P=0.271). Persistence of symptoms within 3 months of H. pylori eradication and female sex were predictive of persistence of symptoms in the following 6-7 years, in patients with functional dyspepsia. In turn, approximately 50% of the patients with complete symptom remission, within 6 months of H. pylori eradication, later became symptomatic. Since the end of the H. pylori eradication trial, 26.9% of patients were still using or had used antidyspeptic drugs; patients with functional dyspepsia having used them more frequently than duodenal ulcer patients (36.4 vs. 16.3%; P=0.037). CONCLUSION: In clinical practice, long-term symptomatic benefit, in duodenal ulcer patients, after H. pylori eradication, is similar to that in patients with functional dyspepsia. Early evaluation of symptoms after successful H. pylori eradication may be predictive of outcome in dyspeptic patients. Most symptomatic patients did not seek antidyspeptic drugs. Use of antisecretory medications was, however, greater in patients with functional dyspepsia than in duodenal ulcer patients.

KW - Duodenal ulcer

KW - Dyspepsia

KW - Eradication

KW - Helicobacter pylori

KW - Predictors

UR - http://www.scopus.com/inward/record.url?scp=67649624658&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67649624658&partnerID=8YFLogxK

U2 - 10.1097/MEG.0b013e3283069db0

DO - 10.1097/MEG.0b013e3283069db0

M3 - Article

VL - 21

SP - 387

EP - 393

JO - European Journal of Gastroenterology and Hepatology

JF - European Journal of Gastroenterology and Hepatology

SN - 0954-691X

IS - 4

ER -